Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	230.2	435.9	232.77	559.99	162.17	37.22
Short-Term Investments	695.55	753.98	845.37	405.65	137.5	54.63
Cash & Short-Term Investments	925.76	1,190	1,078	965.65	299.67	91.85
Cash Growth	-8.83%	10.36%	11.65%	222.24%	226.27%	-37.28%
Receivables	-	-	-	300	-	-
Prepaid Expenses	19.78	21.17	14.76	7.36	8.65	2.7
Total Current Assets	945.53	1,211	1,093	1,273	308.32	94.54
Property, Plant & Equipment	218.21	237.81	234.13	186.98	125.37	43.25
Long-Term Deferred Charges	-	-	-	-	-	3.1
Other Long-Term Assets	7.63	10.87	14.69	14.47	17.98	15.21
Total Assets	1,171	1,460	1,342	1,474	451.68	156.1
Accounts Payable	3.81	1.62	9.03	7.47	6.31	7.85
Accrued Expenses	25.47	35.05	30.72	56.87	11.96	6.03
Current Portion of Leases	12.94	13.26	12.23	9.83	6.34	5.64
Current Unearned Revenue	89.33	68.71	135.97	86.27	0.02	-
Other Current Liabilities	34.7	86.93	35.64	53	77.7	9.63
Total Current Liabilities	166.24	205.57	223.6	213.44	102.34	29.14
Long-Term Leases	149.13	159.91	168.63	137.82	101.31	25.6
Long-Term Unearned Revenue	57.82	109.89	202.18	262.3	0.39	-
Other Long-Term Liabilities	6.86	3.02	13.84	34.16	2.08	0.42
Total Liabilities	380.05	478.39	608.24	647.72	206.12	55.15
Common Stock	0.83	0.82	0.71	0.68	0.57	0.07
Additional Paid-In Capital	2,265	2,170	1,793	1,594	642.63	1.85
Retained Earnings	-1,476	-1,190	-1,057	-768.27	-397.64	-203.04
Comprehensive Income & Other	1.76	0.6	-2.43	-0.05	-0.01	0.02
Total Common Equity	791.32	981.33	733.47	826.74	245.56	-201.1
Shareholders' Equity	791.32	981.33	733.47	826.74	245.56	100.95
Total Liabilities & Equity	1,171	1,460	1,342	1,474	451.68	156.1
Total Debt	162.07	173.17	180.86	147.64	107.64	31.24
Net Cash (Debt)	763.69	1,017	897.28	818	192.03	60.61
Net Cash Growth	-9.24%	13.31%	9.69%	325.98%	216.82%	-58.61%
Net Cash Per Share	9.33	13.18	12.82	12.74	4.11	9.35
Filing Date Shares Outstanding	79.59	78.73	70.7	67.6	61.14	48.68
Total Common Shares Outstanding	79.35	78.71	69.58	67.26	55.98	7.33
Working Capital	779.29	1,005	869.3	1,060	205.98	65.41
Book Value Per Share	9.97	12.47	10.54	12.29	4.39	-27.45
Tangible Book Value	791.32	981.33	733.47	826.74	245.56	-201.1
Tangible Book Value Per Share	9.97	12.47	10.54	12.29	4.39	-27.45
Machinery	77.12	69.67	54.79	35.23	18.83	13.62
Construction In Progress	2.13	5.28	5.2	7.35	15.88	2.19
Leasehold Improvements	100.92	100.19	85.8	57.76	12.71	12.65

Source: S&P Capital IQ. Standard template. Financial Sources.